Hypertriglyceridemias

Hypertriglyceridemias is the indication for 5 drugs in DrugBank. It is covered by 5 curated, structured indications.

Also known as: Hypertriglyceridaemia · Hypertriglyceridemia · Hyper-Triglyceridemia · hypertryglyceridemia
Classified under: Drugs, Chemicals, and Substances
Nutritional and Metabolic Diseases
Indicated drugs: Atorvastatin
Fenofibric acid
Omega-3-carboxylic acids
Pantethine
Rosuvastatin

Resolves to

Vocabularies

MeSHM0023401SNOMED CT302870006MedDRA10014486UMLSC0020557

What you can answer from here — as of October 24, 2026

5Indicated drugsWith each drug's targets and mechanism

Listed above

5Structured indicationsPopulation, line of therapy, route and combination as fields, not prose

232Clinical trialsPhase, status and sponsor resolved per trial

1Contraindicated drugDrugs whose labels contraindicate them in this condition

52Drugs reporting it as an adverse effectWith incidence where the label states it

Which approved drugs for Hypertriglyceridemias share a target, and which companies have late-stage candidates against it?

Create a free account or log in to explore the full data card.